ZEN Zentek Ltd
- 1.420
- +0.020+1.43%
Zentek Ltd News
Zentek Announces Board and Management Changes
GUELPH, ON / ACCESSWIRE / May 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the following cha
Zentek Advances Air Filter Tech, Eyes Surgical Market
Zentek Provides ZenGUARD(TM) Business Update
GUELPH, ON / ACCESSWIRE / April 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to
Zentek Provides ZenGUARD Business Update
Zentek Provides ZenGUARD Business UpdateGuelph, ON – April 25, 2024, Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property technology development and commerciali
Zentek Partners With Medwell for U.S. Mask Distribution
Zentek Says Potential COVID-19 Drug Shows 'Promising' Safety Profile in Preclinical Trial
Zentek (ZTEK) said Monday a preclinical study by its Triera Biosciences unit of C19HBA showed that this potential therapeutic for COVID-19 has a "promising" safety and toxicity profile. An inflammator
Zentek's C19HBA Shows Promise in Preclinical Studies
Zentek Announces Promising Preclinical Safety and Toxicity Results Achieved by Triera Biosciences Ltd. for C19HBA
GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed
Zentek Announces Promising Preclinical Safety and Toxicity Results Achieved by Triera Biosciences Ltd. For C19HBA
Guelph, ON Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed testing demonstrating that it
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks were higher Tuesday afternoon, with the NYSE Health Care Index 0.1% higher and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) fell 0.8%.
Zentek Shares Rise After Positive Preclinical Results For Covid Treatment Candidate
Zentek (ZTEK) shares were up over 12% in recent trading Tuesday, following positive results from preclinical testing of C19HBA in mice infected with severe acute respiratory syndrome coronavirus 2. Ze
Zentek Brief: Announcing "Positive" Therapeutic Results Achieved by Triera Biosciences for C19HBA
08:29 AM EST, 01/30/2024 (MT Newswires) -- Zentek Brief: Announcing "Positive" Therapeutic Results achieved by Triera Biosciences for C19HBA
Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARDTM-Enhanced HVAC Filters
Guelph, ON Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, is pleased to announce the completion of a new study
Zentek Taps Independent Director as Board Chairman
Zentek Ltd. (Nasdaq:ZTEK and TSX-V:ZEN), an intellectual property development and commercialization company, said Friday that Francis Dube has resigned as chairman of the company's board, effective Ja
Zentek Brief: Announcing Eric Wallman Appointed as Chairman of the Board
08:47 AM EST, 01/19/2024 (MT Newswires) -- Zentek Brief: Announcing Eric Wallman Appointed as Chairman of the Board
Zentek Announces Eric Wallman Appointed as Chairman of the Board
GUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. , an intellectual property development and commercialization company, announces that
Zentek Announces Eric Wallman Appointed as Chairman of The Board
Guelph, ON Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, announces that effective January 12th, Dr. Francis Du
Zentek Launches Triera, a New Subsidiary, to Commercialize Its Aptamer Covid-19 Treatment
Zentek (ZEN.V) on Wednesday said it is forming a new subsidiary to advance its aptamer platform technology for the treatment of Covid-19 developed with McMaster University. The intellectual property c
Zentek Launches Triera Biosciences Ltd.
GUELPH, ON / ACCESSWIRE / December 13, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces
